INGN Q4 2023 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$76M-13.8% YoY

Gross Profit

$28M37.1% margin

Operating Income

-$29M-38.2% margin

Net Income

-$27M-35.0% margin

EPS (Diluted)

$-1.14

QoQ Revenue Growth

-9.6%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$9M

Stock-Based Comp.

-$1M

Balance Sheet

Total Assets

$326M

Total Liabilities

$121M

Stockholders' Equity

$205M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$88M	-13.8%
Gross Profit	$28M	$29M	-4.5%
Operating Income	-$29M	-$58M	+50.4%
Net Income	-$27M	-$57M	+53.1%

Geographic Segments

UNITED STATES

$54M72%

Non-US

$22M28%